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INTRODUCTION

The role of the community pharmacist within the healthcare system
is vital. As healthcare moves towards value-based payments it is
important that pharmacist contributions are fully realized. One
barrier to proving this value is the lack of a standardized system to
track and capture the types and quantity of interventions made by
pharmacy students and community pharmacists.
Documentation is a key parameter of the Pharmacists Patient Care
Process; however, methods of documentation differ significantly
across community practice sites. Standard definitions for
medication therapy problems exist. However, no standardized
definitions for interventions made to resolve MTPs were discovered
in the literature.

RESULTS
TABLE 1: SURVEY RESPONSES

DEMOGRAPHICS
Respondents included pharmacists (40%) and students
(60%). 114 participants started the survey ; 75 completed
the entire survey. Student surveys were excluded if they
did not have knowledge of medication related problems
(17) for a total of 58 surveys included in the final analysis.
Figure 2: Practice Environment
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Survey Development: The study team developed 8 case
scenarios representing common situations to the community
pharmacy setting. Participants were provided with
intervention categories and definitions (Figure 1) and were
instructed to choose the “best” intervention category for the
scenario described.
Ethics: The study was deemed exempt by the Institutional
Review Boards of Thomas Jefferson and Binghamton
Universities.
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DISCUSSION

CONCLUSIONS

• Linguistics is a complicated study of language, including
semantics and syntax. English, by nature, is a complicated
language linguistically. Therefore, we inquired if English was
the first language of the study participants, which was the case
In all except for three contributors.
• PQA’s Medication Therapy Problem list was utilized to develop
the problems. No standard list, within primary literature or
professional pharmacy organizations, was found for
interventions. Therefore, interventions were determined and
defined by the researchers from a variety of sources.
• All scenarios yielded at least two different responses.
• Most scenarios (7/8) produced results consistent with the
researcher coding. One scenario produced results inconsistent
with those coded during survey development.
• Practicing pharmacists showed less variation in intervention
chosen than their student counterparts.
• Students are taught to identify and categorize medication
related problems (MRPs) or drug related problems (DRPs) in
the doctor of pharmacy curriculum; however, results from this
study support the need to spend additional time addressing
appropriate classification of interventions. This can affect
reimbursement and perceived values of “worth.”
Limitations:
• No focus group to determine the “expected” answer - just based
on researcher experience.
• Small sample size – pilot study.

The ability of pharmacists and students to apply a common set of
definitions to their interventions is important because interventions
can be tied to different potential outcomes, which may affect
reimbursement rates. The results of this study show that there are
inconsistencies in categorization of interventions by pharmacists,
even when provided with a common definition list. Inconsistencies
are even higher among students. If pharmacists are unable to
commonly categorize their actions in order to document their
interventions in a standardized manner, this could mean that further
training in this area of documentation is needed in pharmacy school
or beyond.
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METHODS
Study Population: Participants were recruited via email
from affiliated university student and preceptor listservs and
local pharmacy organizations; students were limited to those
who had learned about drug related problems/medication
related problems. A chance to win a $50 gift card was
offered as an incentive to participate.
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OBJECTIVE

Study Design: This was a prospective pilot survey.
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Figure 3: Years of Service
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The purpose of this study is to evaluate the vocabulary students
and pharmacists are using to denote the intervention they are
performing in the community pharmacy setting. If students can
utilize a standardized definition sheet to categorize their
interventions, one tracker tool can be used to facilitate experiential
education.
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CASE T HEMES

INTERVENTION

DEFINITION

New therapy initiated

• Addition of drug for untreated/undertreated indication
• Addition of medical device for administration of drug ( i.e pen needles,
syringe, spacer)
• Administration of vaccine

Therapy discontinued

Drugs with no indication removed from medication regimen
Prescriptions for duplicate drugs discontinued

Dose altered

• Medication dose increased/decreased due to:
o Drug interaction
o Disease precaution
o Laboratory values
o Adverse drug reaction

Administration route
changed

• Administration route optimized for patient

Duration altered

• Duration of treatment changed to clinically recognized dosing parameters

Drug Monitoring

• Request for therapeutic drug monitoring ( INR, blood pressure, weight,
laboratory values)

Drug changed

• Medication changed due to:
o Insurance formulary
o Cost
o Generic equivalent available
o Guideline recommendation
o Intolerability/adherence issue

Administration technique • Device education performed
altered
• Patient changed or altered administration of a drug or device
• Adherence counseling resulting in administration technique change
Patient contacted
healthcare provider

• Request for patient follow-up with provider regarding drug, side effect,
monitoring or other factor related to drug regimen

Intervention declined

• The pharmacist took an action recommending any of the other interventions
and the patient or prescriber declined

Figure 1: Definitions provided within survey to help standardize which words are associated with
the intervention

The implications of this research will be utilized in the development
of a community pharmacy intervention tracking tool for use by
pharmacy students on rotation. The goal of this tool is to help
students practice documentation and demonstrate pharmacy student
worth through interventions completed.
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